ginsenoside-rg3 has been researched along with Mouth-Neoplasms* in 1 studies
1 other study(ies) available for ginsenoside-rg3 and Mouth-Neoplasms
| Article | Year |
|---|---|
RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).\ \ This article has been retracted at the request of the Editor-in-Chief.\ \ Given the comments regarding this article https://pubpeer.com/publications/917A4D8593F06C8E5ADC7AA0A30136, particularly regarding the background of the Western Blots from Figure 2B, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article. Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Ginsenosides; Humans; Male; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Mouth Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2019 |